Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
The DOI matches its Crossref record; 484 of the 491 references it cites were found in a registry or an index.
Abstract
Metformin is an insulin sensitizer widely used for the treatment of patients affected by type 2 diabetes mellitus. Because many women with polycystic ovary syndrome (PCOS) are insulin resistant, metformin was introduced in clinical practice to treat these patients also. Moreover, metformin's effect has other targets beside its insulin-sensitizing action. The present review was aimed at describing all evidence-based and potential uses of metformin in PCOS patients. In particular, we will analyze the uses of metformin not only for the treatment of all PCOS-related disturbances such as menstrual disorders, anovulatory infertility, increased abortion, or complicated pregnancy risk, hyperandrogenism, endometrial, metabolic and cardiovascular abnormalities, but also for the prevention of the syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the beneficial effects of metformin are increasingly evident, especially when combined with lifestyle modifications, improving the pathogenetic mechanisms underlying PCOS, restoring ovarian function, and improving metabolic profile, especially insulin sensitivity and, unlike COCs, lipoprotein pattern [49].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [49]
In the citing paper
“Metformin has been used extensively in DM2, is the most studied in PCOS, and has the most reassuring safety profile. 222”
From Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline (2011) · cites this paper as [222]
Citations
Cites
4 retracted
Items 401–484 of 484
Bolton, S., Cleary, B., Walsh, J., Dempsey, E., & Turner, M. J. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0737-7 · Cited by 45
Pharmacological Management of Gestational Diabetes
Coustan, D. R. (2007) · Diabetes Care · doi:10.2337/dc07-s217 · Cited by 45
Bruno, R. V., de Ávila, M. A. P., Neves, F. B., Nardi, A. E., Crespo, C. M. S., & Sobrinho, A. T. C. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.133 · Cited by 45
Metformin prolongs the postprandial fall in plasma ghrelin concentrations in type 2 diabetes
English, P. J., Ashcroft, A., Patterson, M., Dovey, T. M., Halford, J. C. G., Harrison, J., Eccleston, D., Bloom, S. R., Ghatei, M. A., & Wilding, J. P. H. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.681 · Cited by 44
He, G., Pedersen, S. B., Bruun, J. M., Lihn, A. S., & Richelsen, B. (2003) · Hormone and Metabolic Research · doi:10.1055/s-2003-38386 · Cited by 43
Comparison of metformin versus rosiglitazone in patients with Acanthosis nigricans: a pilot study.
Bellot-Rojas, P., Posadas‐Sánchez, R., Caracas-Portilla, N., Zamora‐González, J., Cardoso-Saldaña, G. C., Cruz, F. J., & Posadas‐Romero, C. (2006) · PubMed · Cited by 42
SCHEEN, A. J., FERREIRA ALVES de MAGALHAES, A. C., SALVATORE, T., & LEFEBVRE, P. J. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02257.x · Cited by 42
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
Stambolic, V., Woodgett, J. R., Fantus, I. G., Pritchard, K. I., & Goodwin, P. J. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-0015-4 · Cited by 42
Effects of metformin on insulin receptor tyrosine kinase activity in rat adipocytes
Jacobs, D. B., Hayes, G. R., Truglia, J. A., & Lockwood, D. H. (1986) · Diabetologia · doi:10.1007/bf00873219 · Cited by 40
Kusaka, I., Nagasaka, S., Horie, H., & Ishibashi, S. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00857.x · Cited by 40
Komajda, M., Curtis, P., Hanefeld, M., Beck-Nielsen, H., Pocock, S. J., Zambanini, A., Jones, N. P., Gomis, R., Home, P. D., & RECORD Study Group, F. T. (2008) · Cardiovascular Diabetology · doi:10.1186/1475-2840-7-10 · Cited by 40
Preiss, D., Sattar, N., Harborne, L., Norman, J., & Fleming, R. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01825.x · Cited by 39
Strowitzki, T., Halser, B., & Demant, T. (2002) · Gynecological Endocrinology · doi:10.1080/713602996 · Cited by 39
Vanky, E., Salvesen, K. A., & Carlsen, S. M. (2004) · Human Reproduction · doi:10.1093/humrep/deh103 · Cited by 39
van Santbrink, E. J. P., Hohmann, F. P., Eijkemans, M. J. C., Laven, J. S. E., & Fauser, B. C. J. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01866 · Cited by 37
Genazzani, A. D., Strucchi, C., Luisi, M., Casarosa, E., Lanzoni, C., Baraldi, E., Ricchieri, F., Mehmeti, H., & Genazzani, A. R. (2006) · Gynecological Endocrinology · doi:10.1080/09513590500476164 · Cited by 36
AJOSSA, S., Guerriero, S., Paoletti, A. M., Orrù, M., & Melis, G. B. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03101-1 · Cited by 36
Metformin before and during pregnancy and lactation in polycystic ovary syndrome
Glueck, C. J., & Wang, P. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.2.191 · Cited by 36
Yoa, R. G., Rapin, J. R., Wiernsperger, N. F., Martinand, A., & Belleville, I. (1993) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1993.tb01742.x · Cited by 35
How should we manage atherogenic dyslipidemia in women with polycystic ovary syndrome?
Rizzo, M., Berneis, K. K., Carmina, E., & Rini, G. B. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.014 · Cited by 35
Strowitzki, T., Corleta, H. V. E., Kellerer, M., & Häring, H. U. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55674-x · Cited by 35
Effects of metformin treatment in women with polycystic ovary syndrome depends on insulin resistance
Nawrocka-Rutkowska, J., & Starczewski, A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701260193 · Cited by 34
Audia, P. F., Feinfeld, D. A., Dubrow, A. J., & Winchester, J. F. (2008) · Clinical Toxicology · doi:10.1080/15563650701355314 · Cited by 34
Palomba, S., Orio, F., Falbo, A. I., Russo, T., Caterina, G., Manguso, F., Tolino, A., Colao, A., & Zullo, F. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02392.x · Cited by 34
Self-citationSahin, I., Serter, R., Karakurt, F., Demirbas, B., Culha, C., Taskapan, C., Kosar, F., & Aral, Y. (2004) · Gynecological Endocrinology · doi:10.1080/09513590400004736 · Cited by 34
Tsilchorozidou, T., Batterham, R. L., & Conway, G. S. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03285.x · Cited by 33
Utero-ovarian arterial blood flow and hormonal profile in patients with polycystic ovary syndrome
Bokal, E. V., & Meden‐Vrtovec, H. (1998) · Human Reproduction · doi:10.1093/humrep/13.4.815 · Cited by 33
Estrogen Use and Cancer Risk: A Review
LUPULESCU, A. P. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211234 · Cited by 32
Pathogenesis of Type 2 Diabetes: Implications for Metformin
DeFronzo, R. A. (1999) · Drugs · doi:10.2165/00003495-199958001-00008 · Cited by 32
Carcinoma of the endometrium in young women
Hellman, L. (1950) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(50)90387-5 · Cited by 32
Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome
Öktenli, Ç., Özgürtaş, T., Dede, M., Sanısoğlu, Y., Yenen, M. C., Yeşilova, Z., Kenar, L., Kurt, Y. G., Başer, İ., Smith, J., et al. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701666571 · Cited by 31
Metformin Overdose With a Resultant Serum pH of 6.59: Survival Without Sequalae
Dell’Aglio, D. M., Perino, L. J., Todino, J. D., Algren, D. A., & Morgan, B. (2008) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2007.09.034 · Cited by 31
Clomiphene Versus Metformin for Ovulation Induction in Polycystic Ovary Syndrome: The Winner Is ….
Barbieri, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1393 · Cited by 31
Marcondes, J. A. M., Yamashita, S. A. Y., Maciel, G. A. R., Baracat, E. C., & Halpern, A. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701192529 · Cited by 30
Gao, H., Xiao, W., Wang, C., Zhang, J., Yang, Y., Yang, J. O., Yang, W., & Hong, T. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01733.x · Cited by 30
Santos, R. F., Nomizo, R., Wajhenberg, B. L., Reaven, G. M., & Azhar, S. (1995) · PubMed · Cited by 29
Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell line
Puljak, L., Parameswara, V., Dolovcak, S., Waldrop, S. L., Emmett, D. S., Esser, V., Fitz, J., & Kilic, G. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.03.002 · Cited by 29
Romualdi, D., Marinis, L. D., Campagna, G., Proto, C., Lanzone, A., & Guido, M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03204.x · Cited by 29
Basir, G. S., Lam, T. P. W., Chau, M. T., Ng, E. H. Y., Wai‐Sum, O., & Ho, P. C. (2001) · Human Reproduction · doi:10.1093/humrep/16.10.2114 · Cited by 29
Ibáñez, L., Valls, C., & de Zegher, F. (2006) · Human Reproduction · doi:10.1093/humrep/dei329 · Cited by 28
Sinawat, S., Buppasiri, P., Lumbiganon, P., & Pattanittum, P. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006226.pub3 · Cited by 27
Topçu, S., Tok, D., Çalışkan, M., Özçimen, E. E., Güllü, H., Üçkuyu, A., Erdoğan, D., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02551.x · Cited by 27
Premicroalbuminuria in Women with Polycystic Ovary Syndrome: A Metabolic Risk Marker
Patel, A. A., Bloomgarden, Z. T., & Futterweit, W. (2008) · Endocrine Practice · doi:10.4158/ep.14.2.193 · Cited by 26
Guastamacchia, E., Resta, F., Triggiani, V., Liso, A., Licchelli, B., Ghiyasaldin, S., Sabba, C., & Tafaro, E. (2004) · Current Drug Targets - Immune, Endocrine & Metabolic Disorders · doi:10.2174/1568008043339965 · Cited by 26
Tessari, P., & Tiengo, A. (2008) · Acta Diabetologica · doi:10.1007/s00592-008-0032-0 · Cited by 24
Kjøtrød, S. B., Sunde, A., von Düring, V., & Carlsen, S. M. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.069 · Cited by 22
Metformin hydrochloride and recurrent miscarriage in a woman with polycystic ovary syndrome
Palomba, S., Falbo, A. I., Orio, F., Russo, T., Tolino, A., & Zullo, F. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.09.063 · Cited by 22
Self-citationClinical Manifestations of Polycystic Ovarian Disease
Young, R. L., & Goldzieher, J. W. (1988) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30401-8 · Cited by 22
Utility of screening for other causes of infertility in women with “known” polycystic ovary syndrome
McGovern, P. G., Legro, R. S., Myers, E. R., Barnhart, H. X., Carson, S. A., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., Steinkampf, M. P., et al. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.06.050 · Cited by 20
Metformin-associated lactic acidosis following contrast media-induced nephrotoxicity
Jain, V., Sharma, D., Prabhakar, H., & Dash, H. H. (2007) · European Journal of Anaesthesiology · doi:10.1017/s026502150700097x · Cited by 19
Expression of glucose transporter 1 in human endometrial and decidual tissue
Strowitzki, T., Capp, E., von Wolff, M., & Müller‐Höcker, J. (2001) · Gynecological Endocrinology · doi:10.1080/gye.15.3.219.224 · Cited by 19
Metformin use in infertile patients with polycystic ovary syndrome: an evidence-based overview
Palomba, S., Oppedisano, R., Tolino, A., Orio, F., & Zullo, F. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60592-5 · Cited by 18
Self-citationInsulin-sensitizing agents and reproductive function in polycystic ovary syndrome patients
Palomba, S., Falbo, A. I., Orio, F., & Zullo, F. (2008) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328307ebc5 · Cited by 18
Self-citationLiu, K. E., TATARYN, I. V., & Sagle, M. A. (2006) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)32202-2 · Cited by 18
Kawai, T., Funae, O., Shimada, A., Tabata, M., Hirata, T., Atsumi, Y., & Itoh, H. (2008) · Internal Medicine · doi:10.2169/internalmedicine.47.0969 · Cited by 17
Cataldo, N. A., Barnhart, H. X., Legro, R. S., Myers, E. R., Schlaff, W. D., Carr, B. R., Diamond, M. P., Carson, S. A., Steinkampf, M. P., Coutifaris, C., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0287 · Cited by 17
Cacciatore, B., Simberg, N. H., Tiitinen, A. E., & Ylikorkala, O. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81401-x · Cited by 17
Uncu, G., Sözer, M. C., Develioğlu, O. H., & Cengiz, C. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.6.447.452 · Cited by 15
Metabolism of Glucose in the Human Endometrium with Special Reference to Fertility and Contraception
Hackl, H. (1973) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347309158301 · Cited by 14
Komori, T., Hotta, N., Kobayashi, M., Sakakibara, F., Koh, N., & Sakamoto, N. (1993) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(93)90127-q · Cited by 14
McGovern, P. G., Carson, S. A., Barnhart, H. X., Myers, E. R., Legro, R. S., Diamond, M. P., Carr, B. R., Schlaff, W. D., Coutifaris, C., Cataldo, N. A., et al. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.004 · Cited by 13
Bromer, J. G., Çetinkaya, M. B., & Arici, A. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1434.004 · Cited by 13
Palomba, S., Orio, F., & Zullo, F. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701414212 · Cited by 13
Self-citationMatthaei, S., Hamann, A., Hh, K., Benecke, H., Kreymann, G., Flier, J. S., & Greten, H. (1992) · PubMed · Cited by 12
Khan, N. A., Wiernsperger, N. F., Quémener, V., & Moulinoux, J.-P. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1420245 · Cited by 11
Umehara, K.-I., Iwatsubo, T., Noguchi, K., & Kamimura, H. (2008) · Journal of International Medical Research · doi:10.1177/147323000803600116 · Cited by 11
Metformin use during the first trimester of pregnancy. Is it safe?
Koren, G., Gilbert, C. J., & Valois, M. (2006) · Europe PMC (PubMed Central) · Cited by 10
Basal, oxytocin-, and insulin-stimulated glucose oxidation in human endometrium
Truchan, B., Taylor, P. J., Goren, H. J., Lederis, K. P., Hollenberg, M. D., & Okabe, T. (1987) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y87-056 · Cited by 10
Decaestecker, K., Philibert, P., Baere, E. B. W. D., Hoebeke, P. B., Kaufman, J., Sultan, C., & T'Sjoen, G. G. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.04.057 · Cited by 10
Effect of Metformin in Asian Indian Women with Polycystic Ovarian Syndrome
Misra, S., Parida, N., Das, S., Parija, B. S., Padhi, M., & Baig, M. A. A. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.192 · Cited by 9
Therapeutic response to metformin in an underweight patient with polycystic ovarian syndrome
Al‐Ozairi, E., Quinton, R., & Advani, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.11.041 · Cited by 9
Shibahara, H., Kikuchi, K., Hirano, Y., Suzuki, T., Takamizawa, S., & Suzuki, M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.021 · Cited by 8
Acute renal failure from contrast medium: Beware patients taking metformin…
Sayer, J. A. (2006) · BMJ · doi:10.1136/bmj.333.7569.653-a · Cited by 8
Rikimaru, M., Nishikawa, T., Shimizu, Y., Ishida, N., Katsube, J., Kadota, T., & Saijo, S. (1965) · PubMed · Cited by 7
Берштейн, Л. М., Vb, G., Kvachevskaia, I. O., Tsyrlina, E. V., & Kovalenko, I. G. (2000) · PubMed · Cited by 7
Acute alopecia due to metformin treatment for polycystic ovarian syndrome
Jothilakshmi, P. K., Watson, A. J. S., & Jude, E. B. (2006) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610600831266 · Cited by 6
Runge, S., Alte, D., Baumeister, S., & Völzke, H. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1065319 · Cited by 6
Triplet pregnancy after metformin in a woman with polycystic ovary syndrome
Clapauch, R., & Mattos, T. M. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.05.034 · Cited by 6
George, J. T., & McKay, G. A. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02411.x · Cited by 5
Li, L., Yang, C., & Qiaojie (1998) · PubMed · Cited by 5
Endometrial gene expression in women with polycystic ovary syndrome.
Pillay, O. D. C., Leonard, A., Catalano, R. D., Sharkey, A., & Hardiman, P. J. (2005) · UCL Discovery (University College London) · Cited by 4
Metformin in therapy naive patients with polycystic ovary syndrome
Palomba, S., & Falbo, A. I. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmm049 · Cited by 4
Self-citationAuto-immune neutropenia associated with metformin in a patient with splenic marginal zone lymphoma
Laporte, F., Hamdi, S. M., Oksman, F., & Huguet, F. (2008) · Pharmacy World & Science · doi:10.1007/s11096-008-9218-3 · Cited by 3
Wild, R. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.09.013 · Cited by 1
Research works printed but not linked: 5
- 2005, American Association of Clinical Endocrinologists position statements on metabolic and cardiovascular consequences of polycystic ovary syndrome., Endocr Pract, 11, 126
- Deaton, 1991, Hyperandrogenism and uterine bleeding., Infertil Reprod Med Clin North Am, 2, 561
- 1992, Recent advances in medically assisted conception., WHO Tech Rep Ser, 820, 1
- Sonntag, 2005, Metformin alters insulin signaling and viability of human granulosa cells., Fertil Steril, 84, 1173, 10.1016/j.fertnstert.2005.04.043 · DOI
- Koschinsky, 1988, Influence of metformin on vascular cell proliferation., Diabetes Metab, 14, 566
Cited by
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“As first-step therapy for anovulation, no consistent evidence suggests that metformin is better than clomiphene citrate regarding cumulative ovulation, pregnancy or live-birth rates”
BackgroundThe Mammalian Ovary from Genesis to Revelation
Edson, M. A., Nagaraja, A. K., & Matzuk, M. M. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0012 · Cited by 820
“For a more extensive review of the pathophysiology and potential genes involved in polycystic ovarian syndrome, the reader is referred to previous work in this journal (272, 273).”
Background
Metadata
- Authors
- Palomba, S., Falbo, A., Zullo, F., & Orio, F.
- Affiliations
- Magna Graecia University (IT)
- Parthenope University of Naples (IT)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-12-04
- Volume
- 30
- Issue
- 1
- Pages
- 1-50
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2160472557
- Cited by
- 426
- References
- 491
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 20 · 2023: 28 · 2022: 25 · 2021: 18 · 2020: 15 · 2019: 19 · 2018: 19 · 2017: 15 · 2016: 18 · 2015: 26 · 2014: 37 · 2013: 40 · 2012: 33
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- CINECA IRIS Institutial research information system (Parthenope University of Naples) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Keywords
- metformin, polycystic ovary syndrome, insulin sensitization, insulin resistance, menstrual disorders, anovulatory infertility, pregnancy complications, hyperandrogenism, endometrial abnormalities, cardiovascular risk, PCOS prevention, type 2 diabetes
- MeSH terms
- Anovulation, Cardiovascular Diseases, Endometrium, Female, Humans, Hypoglycemic Agents, Menstruation Disturbances, Metformin, Obesity, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Complications, Quality of Life, Endometrial Neoplasms, Hyperandrogenism, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.